Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 …
AF Barker, AE O'Donnell, P Flume… - The lancet Respiratory …, 2014 - thelancet.com
Background The clinical benefit of inhaled antibiotics in non-cystic fibrosis bronchiectasis
has not been established in randomised controlled trials. We aimed to assess safety and …
has not been established in randomised controlled trials. We aimed to assess safety and …
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
IF Laska, ML Crichton, A Shoemark… - The lancet respiratory …, 2019 - thelancet.com
Background Although use of inhaled antibiotics is the standard of care in cystic fibrosis,
there is insufficient evidence to support use of inhaled antibiotics in patients with …
there is insufficient evidence to support use of inhaled antibiotics in patients with …
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
We conducted a meta-analysis of randomised trials to evaluate the efficacy and safety of
inhaled antibiotics in patients with stable non-cystic fibrosis (CF) bronchiectasis. We …
inhaled antibiotics in patients with stable non-cystic fibrosis (CF) bronchiectasis. We …
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
C Wong, L Jayaram, N Karalus, T Eaton, C Tong… - The Lancet, 2012 - thelancet.com
Background Azithromycin is a macrolide antibiotic with anti-inflammatory and
immunomodulatory properties. We tested the hypothesis that azithromycin would decrease …
immunomodulatory properties. We tested the hypothesis that azithromycin would decrease …
Efficacy and safety of long‐term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta‐analysis
JW Yang, LC Fan, HW Lu, XY Miao… - The clinical …, 2016 - Wiley Online Library
Abstract Background and Aims The evidence supported the use of nebulized antibiotics in
non‐cystic fibrosis (non‐CF) bronchiectasis is indefinite. A meta‐analysis was performed to …
non‐cystic fibrosis (non‐CF) bronchiectasis is indefinite. A meta‐analysis was performed to …
[HTML][HTML] Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
CE Wainwright, AL Quittner, DE Geller… - Journal of Cystic …, 2011 - Elsevier
BACKGROUND: Previous aztreonam for inhalation solution (AZLI) studies included patients
with cystic fibrosis, Pseudomonas aeruginosa (PA) airway infection, and forced expiratory …
with cystic fibrosis, Pseudomonas aeruginosa (PA) airway infection, and forced expiratory …
[HTML][HTML] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis
GA Anwar, SC Bourke, G Afolabi, P Middleton… - Respiratory …, 2008 - Elsevier
We describe our institutional efficacy experience of azithromycin 250mg thrice weekly in
adult non-cystic fibrosis bronchiectasis. METHODS: Eligibility criteria for prophylactic …
adult non-cystic fibrosis bronchiectasis. METHODS: Eligibility criteria for prophylactic …
Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm …
Background Bronchiectasis guidelines recommend antibiotics for the treatment of acute
respiratory exacerbations, but randomised placebo-controlled trials in children are lacking …
respiratory exacerbations, but randomised placebo-controlled trials in children are lacking …
Aerosolized antibiotics for non-cystic fibrosis bronchiectasis
BK Rubin - Journal of Aerosol Medicine and Pulmonary Drug …, 2008 - liebertpub.com
There are strong data supporting using the use of aerosolized antibiotics for the treatment of
Gram-negative infections in patients with cystic fibrosis (CF). The regular use of aerosol …
Gram-negative infections in patients with cystic fibrosis (CF). The regular use of aerosol …
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
DJ Serisier, D Bilton, A De Soyza, PJ Thompson… - Thorax, 2013 - thorax.bmj.com
Background The delivery of antipseudomonal antibiotics by inhalation to Pseudomonas
aeruginosa-infected subjects with non-cystic fibrosis (CF) bronchiectasis is a logical …
aeruginosa-infected subjects with non-cystic fibrosis (CF) bronchiectasis is a logical …
相关搜索
- fibrosis bronchiectasis inhalation solution
- fibrosis bronchiectasis inhaled antibiotic
- fibrosis bronchiectasis efficacy and safety
- lung impairment inhalation solution
- fibrosis bronchiectasis azithromycin for prevention
- fibrosis bronchiectasis dry powder
- lung impairment cystic fibrosis
- fibrosis bronchiectasis meta analysis
- cystic fibrosis inhalation solution
- fibrosis bronchiectasis aerosolized antibiotics
- fibrosis bronchiectasis prevention of exacerbations